Krainer Adrian R.
Stoke Therapeutics, Inc. · Director
Krainer Adrian R. is listed in filings as Director at Stoke Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Stoke Therapeutics, Inc. (STOK). The current snapshot covers public activity from Jun 4, 2025 to Jun 5, 2026. Reported amounts are shown as $524.0K to $286.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $287k7.2k shares | SellMar 2, 2026 | $39.66 | $29.11 | |
| $1M40.5k shares | SellNov 24, 2025 | $29.72 | $29.11 | |
| $565k20.7k shares | SellNov 14, 2025 | $27.34 | $29.11 | |
| $527k19.8k shares | SellNov 14, 2025 | $26.61 | $29.11 |